Eli Lilly warns weight-loss drug Zepbound may be hard to get

Eli Lilly warns weight-loss drug Zepbound may be hard to get

Eli Lilly & Co. said that some patients may have trouble getting its new weight loss drug Zepbound as complaints of backorders and delays mount across the US. “Due to the unprecedented demand for these medicines, some patients may experience difficulty when trying to fill their prescription at their pharmacy,” a Lilly spokesperson said. The US Food and Drug Administration doesn’t currently consider the obesity shot in shortage and Lilly said it “continues to manufacture and ship all doses of …